These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 6817559

  • 1. [Cell-free Pseudomonas vaccine. IV. Laboratory trials of the effectiveness of experimental Pseudomonas vaccines].
    Stanislavskiĭ ES, Joó I, Bulk VF, Zhvanetskaia MI, Mashilova GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Oct; (10):25-9. PubMed ID: 6817559
    [Abstract] [Full Text] [Related]

  • 2. Vaccines against Pseudomonas aeruginosa infection: 1. Experimental studies.
    Stanislavsky ES, Joo I, Mashilova GM, Boolk VF, Boltutsy LG, Zakgeim DA, Severtśova MK, Yedvabnaya LS, Gladus MA, Fatkhinurova TI.
    Vaccine; 1985 Jun; 3(2):128-36. PubMed ID: 3929491
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Active and passive mouse-protecting capacity of Pseudomonas aeruginosa protein vaccines.
    Joó I, Stanislavsky ES, Zhvanetskaya MI, Mashilova GM, Gladus MA.
    Acta Microbiol Acad Sci Hung; 1982 Jun; 29(4):267-75. PubMed ID: 6821018
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES, Lam JS.
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cell-free Pseudomonas vaccine: its immunochemical characteristics and immunogenicity].
    Bandman OA, Edvabnaia LS, Bulk VF, Zhvanetskaia MI, Mashilova GM.
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):44-7. PubMed ID: 3124416
    [Abstract] [Full Text] [Related]

  • 13. [Experimental study of the dynamics of the formation of protective antibodies to the antigens of the slime of Pseudomonas aeruginosa].
    Iushkova NA, Stanislavskiĭ ES, Landsman NM.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Mar; (3):78-83. PubMed ID: 6405564
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection.
    Li P, Wang X, Sun X, Guan Z, Sun W.
    mSphere; 2021 Oct 27; 6(5):e0069921. PubMed ID: 34612675
    [Abstract] [Full Text] [Related]

  • 16. [Experimental immunological effectiveness and safety of pyoimmunogen vaccine against Pseudomonas aeruginosa infection].
    Stanislavskiĭ ES, Ioo I, Severtsova MK, Mashilova GM, Boltutsiĭ LG.
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May 27; (5):70-5. PubMed ID: 6808791
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Pseudomonas aeruginosa preparations for active immunization].
    Nazarchuk LV.
    Vrach Delo; 1991 Jul 27; (7):22-7. PubMed ID: 1771827
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.